Avanir Pharmaceuticals Announces Patient Assistance Program For NUEDEXTA

The new program, which launched in May 2012, provides eligible patients with a 6-month supply of drug, free of charge to help ensure access to NUEDEXTA. Program participants may qualify for ongoing assistance subject to periodic verification of eligibility.

Categories: Treatments  |  Tags: ALS, ALS medical care, ALS treatments, amyotrophic lateral sclerosis, Bob Stehlin, Lou Gehrig's disease, Patient Assistance Program for NUEDEXTA, pseudobulbar affect, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, Rohan Palekar, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis  |  No comments